OncoSure Testing

04/30/2026

Proactive health starts with the right information.

Oncosure is designed to support ongoing monitoring with continued visibility into your health status, while screening for signals associated with 200+ cancer types through one simple blood draw. With up to 97.77% accuracy based on validation data, Oncosure helps provide meaningful insight to support more informed health decisions.

04/29/2026

Everyone’s health story is different, which is why a more personalized approach to screening matters.

Oncosure uses a simple blood draw to look for signals associated with multiple cancer types, helping provide insight that can support more informed conversations with your healthcare provider.

04/24/2026

Many people want a simpler, more proactive way to better understand their health.

Oncosure is designed to do just that, using one blood draw and advanced analysis to identify signals associated with over 200 cancer types.

04/21/2026

On National Healthcare Decisions Day, the focus is on making thoughtful, informed choices about your health.

Tools like Oncosure's multi-cancer detection screening can help provide additional insight, supporting more informed decisions and conversations with your doctor.

04/17/2026

Oncosure is a blood-based multi-cancer detection test that analyzes specific biomarkers to identify signals associated with different types of cancer.

This type of testing is designed to support earlier insight and more informed conversations—helping individuals take a more proactive approach to their health.

04/15/2026

Biomedical laboratory science plays a critical role in how complex information is analyzed, interpreted, and understood.

Behind every result is a process built on precision, consistency, and attention to detail—supporting more informed decisions every step of the way.

04/13/2026

Health decisions aren’t always straightforward. They often start with uncertainty, questions, and the need for clarity.

Our team is here to answer questions, provide clarity, and help you feel more confident in the decisions you’re making.

04/11/2026

With a history of cancer and a BRCA2 gene mutation, ongoing monitoring is essential. In this story, a patient shares how important consistent monitoring is and how Oncosure Testing helps bring confidence and peace of mind along the way.

04/10/2026

Behind every test is a team dedicated to careful analysis and meaningful insight.
Our lab specialists handle every sample with precision and attention, working to uncover information that can help people take a more proactive approach to their health.

Because when it comes to cancer, earlier insight can make all the difference.

04/07/2026

On World Health Day, the focus is on improving health outcomes worldwide. From prevention to early detection, proactive approaches are helping transform how diseases like cancer are identified and managed.

Oncosure is proud to support this shift toward earlier insights and more proactive health strategies.

04/06/2026

Exciting news from Oncosure Testing.

We’ve announced the formation of our Non-Executive Advisory Board, chaired by healthcare advisory leader Elizabeth Fago, as we continue advancing early cancer detection.

Read the full announcement:

HHS AND CMS HEALTHCARE ADVISORY BOARD COMMITTEE MEMBER ELIZABETH FAGO APPOINTED TO CHAIR ONCOSURE NON-EXECUTIVE ADVISORY BOARD WEST PALM BEACH, FL / ACCESS Newswire ...

04/04/2026

Prevention plays a powerful role in cancer control. According to the American Cancer Society, 44% of cancer deaths in the U.S. are linked to modifiable risk factors, showing how lifestyle and environmental exposures can influence long-term cancer risk.

Reducing risk where possible is important and pairing prevention with early detection offers an opportunity to improve outcomes.